47
Ensho Therapeutics raises $15.6M in biotech funding round
Company raise · Raising · Offering $15.6M · Sold $7.3M · WOODCLIFF LAKE, NJ · filed 2026-10-15
52
Ensho Therapeutics, Inc. raises $5M under Reg D
Company raise · Raising · MORRIS PLAINS, NY · Form D filed 2024-11-12
$10M+ raiseFirst raise on EDGAR
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Danielle Andrew Fry | Executive Officer |
| Matthew Andrew McKevitt | Executive Officer |
| Neena Bitritto-Garg | Executive Officer, Director, Promoter |
| James Andrew Whitney | Executive Officer |
| Emily Andrew Weng | Executive Officer |
| Bittoo Kanwar | Executive Officer |
Signed by Neena Bitritto-Garg, President and CEO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
47
Ensho Therapeutics, Inc. raises $20M under Reg D
Company raise · Pre-first close · Offering $20M · WOODCLIFF LAKE, NJ · filed 2026-02-09
47
Ensho Therapeutics, Inc. raises $22.5M under Reg D
Company raise · Closed · Offering $22.5M · Sold $22.5M · MORRIS PLAINS, NY · filed 2025-09-12